Parsons Capital Management Inc Verastem, Inc. Transaction History

Parsons Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$1.06 - $2.1 $13,250 - $26,250	-12,500 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.54 - $4.07 $13,418 - $21,501	-5,283 Reduced 29.71%	12,500 $39,000
Q1 2021 Apr 28, 2021	BUY	$1.9 - $2.82 $9,500 - $14,100	5,000 Added 39.11%	17,783 $44,000
Q3 2019 Nov 12, 2019	SELL	$1.21 - $1.59 $805 - $1,058	-666 Reduced 4.95%	12,783 $15,000
Q1 2019 Apr 26, 2019	SELL	$2.79 - $4.09 $2,834 - $4,155	-1,016 Reduced 7.02%	13,449 $40,000
Q4 2018 Feb 01, 2019	SELL	$3.23 - $7.01 $113 - $245	-35 Reduced 0.24%	14,465 $49,000
Q3 2017 Oct 26, 2017	BUY	$3.01 - $5.41 $43,645 - $78,445	14,500	14,500 $68,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $880M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Parsons Capital Management Inc with notifications on news.